In this article under our “Is it Worth Studying MS Abroad if you are Already Earning Well in India,” we will be assessing the financial worth of doing MS in Biotechnology abroad. We have already covered five MS courses, Mechanical Engineering, Chemical Engineering, Computer Science, Aerospace Engineering and Material Science, in our series which you can check by clicking on the given links. However, if your desired course is MS in Biotechnology, stick around!
Why do Master’s in Biotechnology Abroad?
The global biotechnology market is expected to reach $727.1 billion by 2025 with a growth rate of 7.4%.
So if you wish to make hay while the sun shines, it might be the right time to consider doing a Master’s in Biotechnology course from a top university in the US, Canada, Europe or Australia. It could prove to be the key to a thriving career ahead, especially given the fact that most of the top biotech companies are headquartered in the US or Europe. Canada ranks higher while Australia stands almost at par with India in terms of the biotech industry revenues.
But Is It Financially Worth Doing MS in Biotechnology Abroad?
In spite of the ample scope of Biotechnology in foreign countries, taking the decision to pursue MS abroad is easier said than done. There are a number of factors that need to be considered before taking the leap forward. Although job prospects and opportunities for growth do factor in while assessing the worth of pursuing higher education abroad, it is the financial expenses and the expected amount of returns which are usually the most decisive factors. Would the investment in doing MS abroad give handsome returns? Would the benefits after MS in Biotechnology abroad be worth the hard work and risk of leaving a job in India and giving up on the current salary ? These are some of the questions that determine the decision to do an MS abroad.
We suggest that to take a financially sound decision, one must consider the estimate earnings the investment would bring one. It is for this very purpose, we bring to you a country-wise analysis of the estimate earnings and savings after doing MS in Biotechnology abroad depending upon the current salary you are drawing in India. We have arrived at these outcomes using our Future Earnings Tool. You could use the tool on your own as well to check the results as per your exact current salary.
Before we proceed, please note that the tool takes into account a few assumptions while calculating the future estimate earnings which you should read here before proceeding with the breakup so that you have an informed idea. Also, throughout this analysis, we will be using certain terms the definitions of which we have stated below for your clearer understanding.
- NPV (Net Present Value): It is the discounted difference between the present values of cash inflows and outflows over a fixed period of time. The higher the NPV, the better the investment.
- IRR (Internal Rate of Return): It gives the idea of an investment’s rate of return. The higher the IRR, the smarter it is to invest.
- Profit: It is the money that one is expected to save while studying and working abroad.
For our analyses, we have taken colleges falling between the ranks 1 and 500 for each country and grouped them into distinct rank brackets. For each salary group earned in India, we then analyze the NPV, IRR and Profit for each rank group to assess whether it is worth doing MS in Biotechnology from a certain country. Readers may note that all the figures in the tables below are computed for 10 years from the start of the loan repayment period considering that the loan will be repaid in 5 years.
Should you go Abroad to Pursue Master’s in Biotechnology Course?
United States
If you are earning ₹ 5 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
1.18 Crores
|
67%
|
2.2 Crores
|
|
51-100
|
1 Crore
|
62%
|
1.96 Crores
|
|
101-250
|
79 Lakhs
|
52%
|
1.53 Crores
|
|
251-500
|
81 Lakhs
|
58%
|
1.54 Crores
|
Verdict: Since the NPV is very encouraging, leaving a job in India that earns you ₹ 5 lakhs a year and opting for MS in Biotechnology from the US would be a great investment.
If you are earning ₹ 15 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
13.4 Lakhs
|
14%
|
49.6 Lakhs
|
|
51-100
|
(-) 1 Lakh
|
8%
|
24.7 Lakhs
|
|
101-250
|
(-) 26 Lakhs
|
(-) 7%
|
(-) 18 Lakhs
|
|
251-500
|
(-) 24 Lakhs
|
(-) 8%
|
(-) 17.9 Lakhs
|
Verdict: There is no harm in doing MS in Biotechnology from a top 50 university for the discipline from the US if you are earning ₹ 15 lakhs per annum in India. But for the same salary, if you are not able to make it to a top 50 university, it would not be a smart decision. As the Net present value is negative.
If you are earning ₹ 25 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
(-) 90 Lakhs
|
Negative
|
(-) 1.2 Crores
|
|
51-100
|
(-) 1.04 Crore
|
Negative
|
(-) 1.45 Crores
|
|
101-250
|
(-) 1.3 Crores
|
Negative
|
(-) 1.88 Crores
|
|
251-500
|
(-) 1.27 Crores
|
Negative
|
(-) 1.87 Crores
|
Verdict: The NPV is significantly negative regardless of college ranking. It would not be beneficial to do an MS in Biotechnology from the US if you are already making ₹ 25 lakhs annually in India.
Canada
If you are earning ₹ 5 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
59 Lakhs
|
43%
|
1.2 Crores
|
|
51-100
|
78 Lakhs
|
79%
|
1.41 Crores
|
|
101-250
|
58 Lakhs
|
64%
|
1 Crore
|
|
251-500
|
50 Lakhs
|
57%
|
96 Lakhs
|
Verdict: You do not need to think twice if you are considering doing MS in Biotechnology from Canada if your current salary is ₹ 5 lakhs per year in India. The NPV figures after doing MS in Canada are encouraging at this salary level.
If you are earning ₹ 15 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
(-) 46 Lakhs
|
(-) 30%
|
(-) 54 Lakhs
|
|
51-100
|
(-) 27 Lakhs
|
Negative
|
(-) 30 Lakhs
|
|
101-250
|
(-) 47 Lakhs
|
Negative
|
(-) 64.5 Lakhs
|
|
251-500
|
(-) 54.5 Lakhs
|
Negative
|
(-) 76.4 Lakhs
|
Verdict: The NPV is remarkably negative regardless of college ranking. It would be better to not go for MS in Biotechnology from Canada if you are earning ₹ 15 lakhs per annum working in India.
If you are earning ₹ 25 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
(-) 1.5 Crores
|
Negative
|
(-) 2.23 Crores
|
|
51-100
|
(-) 1.3 Crores
|
Negative
|
(-) 2 Crores
|
|
101-250
|
(-) 1.5 Crores
|
Negative
|
(-) 2.34 Crores
|
|
251-500
|
(-) 1.58 Crores
|
Negative
|
(-) 2.46 Crores
|
Verdict: The NPV figures are awfully negative for colleges of all rankings. We see no reason that you should go to Canada for MS in Biotechnology if you are already earning ₹ 25 lakhs a year in India.
Germany
If you are earning a salary of ₹ 5 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
95.6 Lakhs
|
112%
|
1.68 Crores
|
|
51-100
|
87.2 Lakhs
|
112%
|
1.53 Crores
|
|
101-250
|
69.2 Lakhs
|
99%
|
1.22 Crores
|
|
251-500
|
62 Lakhs
|
88%
|
1.1 Crores
|
Verdict: The NPV figures are promising for colleges of all rankings. It would be a good decision to do MS in Biotechnology from Germany if your current salary is ₹ 5 lakhs/year in India. Try to make it to a top 100 college for Biotechnology to maximize the return on investment.
If you are earning ₹ 15 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
(-) 9.5 Lakhs
|
(-) 3%
|
(-) 3.9 Lakhs
|
|
51-100
|
(-) 18 Lakhs
|
Negative
|
(-) 19 Lakhs
|
|
101-250
|
(-) 36 Lakhs
|
Negative
|
(-) 50 Lakhs
|
|
251-500
|
(-) 43.1 Lakhs
|
Negative
|
(-) 61.5 Lakhs
|
Verdict: The NPV, as well as profit, are negative regardless of college ranking. Leaving the current job and going to Germany for MS in Biotechnology would not be a smart decision if you are already taking home ₹ 15 lakhs annually by working in India.
If you are earning ₹ 25 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
(-) 1.12 Crores
|
Negative
|
(-) 1.74 Crores
|
|
51-100
|
(-) 1.21 Crores
|
Negative
|
(-) 1.88 Crores
|
|
101-250
|
(-) 1.4 Crores
|
Negative
|
(-) 2.2 Crores
|
|
251-500
|
(-) 1.46 Crores
|
Negative
|
(-) 2.31 Crores
|
Verdict: The NPV is dreadfully negative. There is no point in going to Germany for MS in Biotechnology if you are earning ₹ 25 lakhs per annum from a job in India.
Australia
If you are earning ₹ 5 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
66 Lakhs
|
47%
|
1.3 Crores
|
|
51-100
|
61 Lakhs
|
47%
|
1.2 Crores
|
|
101-250
|
43 Lakhs
|
37%
|
88 Lakhs
|
|
251-500
|
37 Lakhs
|
34%
|
79 Lakhs
|
Verdict: Australia seems to be a fine place to do MS in Biotechnology if you are earning ₹ 5 lakhs annually in India. The NPV is positive for the top 500 colleges.
If you are earning ₹ 15 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
(-) 39 Lakhs
|
(-) 20%
|
(-) 41 Lakhs
|
|
51-100
|
(-) 44.4 Lakhs
|
(-) 39%
|
(-) 53 Lakhs
|
|
101-250
|
(-) 62.5 Lakhs
|
Negative
|
(-) 83.8 Lakhs
|
|
251-500
|
(-) 67.7 Lakhs
|
Negative
|
(-) 92.8 Lakhs
|
Verdict: Drop your plans for doing MS in Biotechnology from an Australian university if you are already making ₹ 15 lakhs a year working in India. The NPV is discouraging and negative regardless of college ranking.
If you are earning a salary ₹ 25 lakhs per annum in India:
|
Target College Global Rank
|
NPV
|
IRR
|
Profit
|
|
1-50
|
(-) 1.42 Crores
|
Negative
|
(-) 2.12 Crores
|
|
51-100
|
(-) 1.48 Crores
|
Negative
|
(-) 2.22 Crores
|
|
101-250
|
(-) 1.66 Crores
|
Negative
|
(-) 2.53 Crores
|
|
251-500
|
(-) 1.7 Crores
|
Negative
|
(-) 2.63 Crores
|
